肺MRI在肺部疾病临床评估中应用范围的扩展:Fleischner学会立场声明
该立场声明介绍超短回波时间和零回波时间等MRI技术扩展了肺MRI的临床应用机会,并将肺MRI临床使用建议分为三类:建议当前临床使用、有前景但需进一步验证或监管批准、适合研究性探索;同时为供应商和基础设施提供建议,并指出假设驱动研究方向及前瞻性随机多中心试验的机会。
要点
- 肺MRI无电离辐射,适合儿童、孕妇及需系列纵向随访的患者。
- 超短回波时间和零回波时间技术使肺实质及肺血管疾病评估变得实用。
- Fleischner学会将肺MRI临床使用建议分为三类:建议当前临床使用、有前景但需验证或监管批准、适合研究。
核心结论
- 肺MRI无电离辐射,超短回波时间和零回波时间等新技术扩展了其在肺实质和肺血管疾病评估中的临床应用机会。
- Fleischner学会将肺MRI临床使用建议分为三类:建议当前临床使用、有前景但需进一步验证或监管批准、适合研究性探索。
研究设计与样本
- Fleischner学会立场声明,未报告系统检索方法、样本量或证据分级方法。
诊断标准与关键数值
- Fleischner学会将肺MRI临床使用建议分层为三类:建议当前临床使用、有前景但需进一步验证或监管批准、适合研究性探索。
临床应用与阅片要点
- 肺MRI因无电离辐射,是儿童、孕妇及需系列纵向随访患者的理想检查方式。
- 超短回波时间和零回波时间技术结合多线圈并行采集和加速方法,使肺MRI评估肺实质和肺血管疾病变得实用。
局限性
- 肺实质信号强度低曾限制肺MRI的临床应用。
- 部分肺MRI应用有前景但仍需进一步验证或监管批准。
- 声明建议开展前瞻性随机多中心试验以研究和验证肺MRI方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Pulmonary MRI provides structural and quantitative functional images of the lungs without ionizing radiation, but it has had limited clinical use due to low signal intensity from the lung parenchyma. The lack of radiation makes pulmonary MRI an ideal modality for pediatric examinations, pregnant women, and patients requiring serial and longitudinal follow-up. Fortunately, recent MRI techniques, including ultrashort echo time and zero echo time, are expanding clinical opportunities for pulmonary MRI. With the use of multicoil parallel acquisitions and acceleration methods, these techniques make pulmonary MRI practical for evaluating lung parenchymal and pulmonary vascular diseases. The purpose of this Fleischner Society position paper is to familiarize radiologists and other interested clinicians with these advances in pulmonary MRI and to stratify the Society recommendations for the clinical use of pulmonary MRI into three categories: (a) suggested for current clinical use, (b) promising but requiring further validation or regulatory approval, and (c) appropriate for research investigations. This position paper also provides recommendations for vendors and infrastructure, identifies methods for hypothesis-driven research, and suggests opportunities for prospective, randomized multicenter trials to investigate and validate lung MRI methods.
引用
- Hatabu H, Ohno Y, Gefter WB, et al. Expanding Applications of Pulmonary MRI in the Clinical Evaluation of Lung Disorders: Fleischner Society Position Paper. Radiology. 2020. PMID: 32870136. doi:10.1148/radiol.2020201138
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。